This “Skin Honey” is a revolutionary product in a league of its own. While it is an injectable comprising of Hyaluronic Acid (HA), it’s neither a dermal filler nor a “skin booster”.
It is a radically new approach to treating skin laxity and aims to renew the production of collagen and elastin using a patented technology called NAHYCO. The “Skin Honey” treatment will provide immediate hydration to the face while it works within the tissues to rejuvenate the skin.
Improved skin texture
Stimulates collagen and elastin production
Increase skin firmness and tightens skin
Our clients have reported an overall healthier, more radiant and youthful-looking skin.
Why is this innovative skin bio-remodelling treatment not a dermal filler?
Not all Hyaluronic Acids (HA) are the same; i.e. the HA found in your mosituriser is different to the HA in dermal fillers. One of the key differences is the molecular weight of the HA used which anywhere from 4,000 to 8,000,000 daltons. Lower molecular weight HA is often used for topical products as they tend to have better skin penetration and absorption.
The other difference is the structure of HA. Traditionally, the HA in dermal fillers are cross-linked resulting in a thicker viscosity, making it ideal to volumise and lift, or to be used for contouring and enhancing features. The cross-linking also means increased longevity before it is broken down naturally in the skin.
“Skin honey” contains 64 mg of pure hyaluronic acid (HA), using 32mg of low-molecular weight HA and 32 mg of high-molecular weight HA. Moreover, it has been produced without the use of chemical cross-linking agents (BDDE) meaning it is more biocompatible with a low inflammation response.
As a result Skin Honey is much thinner than the typical Dermal Filler used. This low viscosity means it has extensive spreadability and integrates into the skin tissue where it aims to restores levels of hyaluronic acid naturally found in skin and stimulates the skin cells to produce collagen and elastin (1).
And it’s not a Skin Booster
While “skin honey” is made with non-crossed linked HA, it is not a skin booster nor is it like anything currently available in the aesthetic market. This product does not fill or replace volume. Compared to traditional skin boosters, “skin honey” aims to work on the keratinocytes and fibroblasts to stimulate collagen and elastin production up to 12 times more than single weight HA alone(1). It also activates stem cells in the fat layer known as adipocytes to improve fat tissue renewal(2). Studies have also shown that it promotes wound healing while hydrating the skin(3).
Its innovative nature goes beyond its components and production, and onto the unique delivery method. It requires fewer injections and sessions, treating even the most challenging areas such as the neck and upper hands. This means there is less discomfort during treatment resulting in less downtime.
The treatment itself is relatively quick and straightforward as only 10 injection points are administered. You will notice the “blobs” for the rest of the day but as “skin honey” has a low viscosity and extreme spreadability, these blobs will soon subside as the product spreads into all areas of the face or neck.
There is minimal downtime with most patients being able to return to work immediately. There will be swelling and pinkness at the injection sites but these will resolve themselves within 48 – 72 hours.
Please note that these “bumps” will be noticeable especially for the first 24 hours but their appearance will improve after a couple days.
It is not recommended that you massage them away in an effort to smooth out the “lumps”. The product protocol is to allow the small mounds of product to slowly and gradually make its way to other areas of the tissue by itself.
Furthermore, by massaging the tissue, you will introduce additional inflammation to the skin which is not ideal in this case.
We highly recommend the following post-care instructions as per the product company’s protocol.
For the first two days (includes the day of treatment), please avoid:
Any exercise including yoga
For the first two weeks after your treatment, please avoid:
Sauna, steam bath, icy temperatures or UV radiation by the sun or solarium (tanning beds)
Filler injections in the same are
Facial treatments such as microdermabrasion, chemical peels, IPL, skin needling, etc
For 4 weeks after your treatment, please avoid:
Fractional resurfacing treatments such as PIXEL, Mosaic, Carbon Dioxide laser resurfacing
Any tattoo removals using laser
Tattoo treatments/modifications including cosmetic tattoos
It is also highly recommended that you use Profhilo Haenkenium, an anti-oxidant moisturising cream, to help maintain cellular vitality. Created by the same company, its aim is to help reduce amount of hyaluronic acid loss post-treatment. It also works to protect the skin from premature ageing, restores the protective barrier of sensitive and stressed skin as well as improve overall skin quality. Ideally for all skin types, recommended for daily use twice a day for its soothing and moisturising action.
Yes, it can be dissolved. The enzyme used for traditional dermal fillers (made with hyaluronic acid) will also work for this bio-remodelling injectable as well. However, this product has a high safety profile with no official incidences where dissolving of the product have been required as of September 2022. Note that there has been more than 4.3 million treatments since 2015 and this product is used in more than 80 countries despite it only arriving in Australia in August 2022.
Stellavato A, Corsuto L, D’Agostino A, La Gatta A, Diana P, Bernini P, et al. Hyaluronan Hybrid Cooperative Complexes as a Novel Frontier for Cellular Bioprocesses Re-Activation. PLoS One 2016;11:e0163510.
Hybrid Complexes of High and Low Molecular Weight Hyaluronans Highly Enhance HASCs Differentiation: Implication for Facial Bioremodelling A. Stellavato and M. La Noce et al. Cell Physiol Biochem 2017;44:1078-1092
In vitro analysis of the effects on wound healing of high- and low-molecular weight chains of hyaluronan and their hybrid H-HA/L-HA complexes D’Agostino et al. BMC Cell Biology (2015) 16:19 DOI 10.1186/s12860-015-0064-6